Lithium



Background

  • Primarily used for uni / bipolar depression
  • Narrow therapeutic range (0.6 - 1.0 mmol/L 12 hours post dose).
  • There is no single toxic level - interpret the lithium concentration alongside symptoms, renal function and whether poisoning is acute, acute-on-chronic or chronic.

Adverse Effects of Long Term Therapy

  • Not features of poisoning/toxicity.
  • Acne, hypothyroidism, alopecia & psoriasis, diabetes insipidus

Toxicity

  • Readily absorbed in GI tract over 4 - 6 hours post overdose
  • Renal excretion
  • Elimination t1/2 usually 24 hours, dependent upon renal function (up to 36 h in the elderly and 40 - 50 h in renal impairment).

Features of Toxicity

  • Thirst, polyuria, tremor, dysarthria, ataxia, arrhythmia ± coma
  • Onset may be delayed for up to 24 hours, especially in lithium-naive patients

Poisoning

Acute:

  • Overdose, not taking lithium
  • Usually only mild toxicity, even with markedly raised levels, as brain concentrations are relatively low. More severe features can develop after a delay of several hours, particularly if renal elimination is reduced

Acute-on-Chronic:

  • Overdose in a patient already taking regular Lithium.
  • Tissues are already saturated, so serious toxicity can follow even a modest overdose. Risk is greater with impaired renal function, dehydration or hyponatraemia

Chronic:

  • Most common presentation
  • Carries the greatest risk of neurotoxicity, even with serum concentrations close to the therapeutic range.
  • Precipitants:
    • Dehydration
    • Drugs reducing renal lithium clearance (thiazides, NSAIDs, ACE inhibitors, ARBs)
    • Impaired renal function
    • Dose too high

Lithium Levels

Serum lithium sampling schedule
Presentation Lithium Measurements
Acute ingestion in someone not taking lithium regularly At 6 hours after ingestion, repeat 4 - 6 hours later, then 6 - 12 hourly, guided by clinical features
Patient already taking lithium Immediately, repeat 6 hours after the last dose, then 6 - 12 hourly, guided by clinical features

* Do not use lithium-heparin tubes for lithium samples.


Management

  • Supportive management - A, B, C with correction fluid / electrolyte imbalance
  • Admit all patients who require assessment for a minimum of 24 hours after ingestion - features can be delayed and deterioration can occur after 6 hours, unlike our usual approach to acute ingestions
  • After 24 hours, asymptomatic patients with normal bloods and a lithium concentration < 1 mmol/L can be considered for discharge, with advice to return if symptoms develop
  • Avoid forced diuresis

Gastric Decontamination

  • Activated charcoal is ineffective - does not adsorb lithium
  • Whole bowel irrigation can be considered in severe cases of acute ingestion (refer to TOXBASE for further information) - continue until effluent runs clear.
  • Gastric lavage - no established benefit; can be considered in exceptional circumstances, only once the airway has been protected

Beware

  • Progressive clinical deterioration
  • Life threatening arrhythmias
  • Coma, seizures, respiratory failure
  • Rising serum lithium concentration

Red Flags

  • Impaired renal fxn
  • Serum Li conc > 4 mmol/L in acute on chronic toxicity
  • Serum Li conc > 5 mmol/L in acute toxicity (for consideration of haemodialysis, even without symptoms).

Haemodialysis

Discuss all potential cases with both the National Poisons Information Centre ((01) 809 2566) and the renal team

  • Treatment of choice for severe poisoning, and may prevent irreversible neurotoxicity
  • Haemodiafiltration is an acceptable alternative if haemodialysis is not possible
  • Continue until new neurological and cardiac features have resolved, OR lithium remains stable at < 1 mmol/L
  • Monitor lithium levels regularly after stopping - rebound can occur and repeat sessions may be needed
Indications for haemodialysis (TOXBASE)
Strength of recommendation Criteria
Strongly recommended Severe neurological toxicity - including reduced consciousness, cerebellar signs or convulsions - or life-threatening dysrhythmias, regardless of concentration
Strongly recommended Lithium > 4 mmol/L with impaired renal function, defined here as eGFR < 45 mL/min/1.73 m2
Consider Lithium ≥ 5 mmol/L, even without symptoms
Consider Lithium > 4 mmol/L in acute-on-chronic overdose
Consider Lithium > 2.5 mmol/L in chronic poisoning


Content by Dr SeáUnderwood. Last Review Dr Amy Brennan Dr Amy Brennan 12/11/26.